Patient is now deceased [death].Case (b)(4) is a serious spontaneous case received from a consumer's spouse via a regulatory authority in united states.In united states.This report concerns a patient of unknown age and gender who is now deceased during treatment with intra-articular euflexxa (sodium hyaluronate) solution for injection, 10 mg/ml, 2 ml, weekly, for osteoarthritis from 2017 to an unknown stop date.The patient's spouse mailed a letter and advised that the patient was now deceased.The patient died on an unknown date.Action taken with euflexxa was not applicable.At the time of this report, the outcome of patient was now deceased was fatal.Concomitant medication was not reported.All events in the case were reported as serious.At the time of reporting the case outcome was fatal.Reporter causality: related, company causality: unassessable.Other case numbers: case number, others = mw5079553.This ae occurred in the us and concerns the medical device euflexxa.Please report to your local health authority if required by local law.This ae is not reportable in eu because it did not occur in a eu + efta country and did not result in a corrective action by the manufacturer no corrective action was done by the manufacturer or requested by regulators.
|